Evaluation of Arginase and Nitric oxide levels in Sepsis
Abstract
Introduction: Sepsis is one of the challenges for the doctors who treat critically ill patients. Delay in diagnosis and late administration of antibiotics have been shown to increase mortality in this cohort. In the present study CRP is used as a traditional marker of an acute inflammatory state and infection. In last couple of years use of Arginase as immune marker has increased enormously. An interplay between Arginase and Nitric oxide has also been reported in immune cells including macrophages, lymphocytes etc. due to limited availability of Arginine in sepsis. Keeping all these facts in mind, present study was designed. Aims and
Objectives: To find out the diagnostic role of Arginase and Nitric oxide in sepsis and to compare with CRP level.
Material & Methods: Thirty patients admitted in MICU of Sassoon Hospital, Pune having SIRS and thirty age, sex matched healthy controls were included in this study. Intravenous blood samples were obtained and analyzed. CRP was done by kit method, Arginase activity was estimated by Roman and Ray method while NO levels were measured by Cortas & Wakid method. Results and
Conclusion: The results of this study showed significant increase in the levels of CRP. Serum arginase was also increased significantly with concomitant decrease in the levels of nitric oxide when compared with healthy controls. So we can conclude from the results that nitric oxide and arginase levels along with CRP may be useful in diagnosis of sepsis.
Downloads
References
2. K.A. Kirkeboen and O.A.Strand. The role of nitric oxide in sepsis – an overview. ActaAnaesthesiolScand, 1999; 43:275-288. [PubMed]
3. Markus Munder.Arginase:an emerging key player in the mammalian immune system. British Journal of Pharmacology,2009;158,638 – 651. [PubMed]
4. ChetanaVaishnavi. Immunology and infectious diseases 1996; 6; 144.
5. W.Roman and J. Rays. Colourimetric estimation of arginase in serum. Congress of Clinical Chemistry 1970; 2:121.
6. Najwa KC, Nabil WW. Determination of inorganic nitrate in serum and urine by kinetic reduction method. Clin chem 1990; 36 (8):1440-43. [PubMed]
7. Christina C. Kao, Venkata Bandi, kalplatha K Guntupalli, ManhongWu, Leticia Castillo, Farook Jahoor. Arginine, Citrulline and nitric oxide metabolism in sepsis. Clinical Science 2009;117,23- 30.
8. Keita Miki ,Abhai Kumar, Runkuan Yang , Meaghan E. Killeen, and Russell L. Delude. Extracellular activation of arginase -1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation. Am J PhysiolGastrointest Liver Physiol. 2009 October;297(4): G840- G848.
9. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JM. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000–2006, 2003. [PubMed]
10. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. ClinExpPharmacolPhysiol 34: 906–911, 2007. [PubMed]
11. Eckmann L, Laurent F, Langford TD, Hetsko ML, Smith JR, Kagnoff MF, Gillin FD. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 164: 1478–1487, 2000.
12. Tadie JM, Henno P, Leroy I, Danel C, Naline E, Faisy C, Riquet M, Levy M, Israel-Biet D, Delclaux C. Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 294: L489–L497, 2008.
13. Chiung-I Chang ,C.Liao and LihKuo. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol Heart CircPhysiol 274 : H342-H348, 1998. [PubMed]
14. Boger R.H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the ‘L- Arginine Paradox’ and acts as a novel cardiovascular risk factor. J.Nutr.2004;134,2842S – 2847S.
15. Tran,C.T.,Leiper, J.M. and Vallance P. The DDAH/ADMA/NOS pathway. Atherosclerosis suppl.4,2003;33 – 40. [PubMed]
16. Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res. 2010 Jan 1;85(1):147-54.
OAI - Open Archives Initiative
